Factor Bioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell Therapies

Factor Bioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell Therapies

Source: 
BioSpace
snippet: 

Factor Bioscience Inc. announced the award of a U.S. Department of Defense grant to develop next-generation cell therapy candidates using Factor's patented mRNA, cell-reprogramming, and gene-editing technologies.